A study protocol of vaginal laser therapy in gynecological cancer survivors

References

• Tantivatana T, Rongsriyam K. Treatment outcomes of high-dose-rate intracavitary brachytherapy for cervical cancer: a comparison of Ir-192 versus Co-60 sources. J Gynecol Oncol 2018;29:e86
   PubMed Web of Science ®Google Scholar
• Autorino R, Tagliaferri L, Campitelli M, et al. EROS study: evaluation between high-dose-rate and low-dose-rate vaginal interventional radiotherapy (brachytherapy) in terms of overall survival and rate of stenosis. J Contemp Brachytherapy 2018;10:315–20
   PubMed Web of Science ®Google Scholar
• Ikushima H, Wakatsuki M, Ariga T, et al. Radiotherapy for vaginal cancer: a multi-institutional survey study of the Japanese Radiation Oncology Study Group. Int J Clin Oncol 2018;23:314–20
   PubMed Web of Science ®Google Scholar
• Chapman CH, Maghsoudi K, Littell RD, Chen LM, Hsu IC. Salvage high-dose-rate brachytherapy and external beam radiotherapy for isolated vaginal recurrences of endometrial cancer with no prior adjuvant therapy. Brachytherapy 2017;16:1152–8
   PubMed Web of Science ®Google Scholar
• Viswanathan AN, Lee LJ, Eswara JR, et al. Complications of Pelvic Radiation in Patients Treated for Gynecologic Malignancies. Cancer 2014;120:3870–83
   PubMed Web of Science ®Google Scholar
• Banerjee R, Kamrava M. Brachytherapy in the treatment of cervical cancer: a review. Int J Womens Health 2014;6:555–64
   PubMedGoogle Scholar
• Kollberg KS, Waldenströ m. A, Bergmark K, et al. Reduced vaginal elasticity, reduced lubrication, and deep and superficial dyspareunia in irradiated gynecological cancer survivors. Acta Oncol 2015;54:772–9
   PubMed Web of Science ®Google Scholar
• Morris L, Do V, Chard J, Brand AH. Radiation-induced vaginal stenosis: current perspectives. IJWH 2017;9:273–9
   PubMed Web of Science ®Google Scholar
• Cruz VL, Steiner ML, Pompei LM, et al. Randomized, double-blind, placebo-controlled clinical trial for evaluating the efficacy of fractional CO2 laser compared with topical estriol in the treatment of vaginal atrophy in postmenopausal women. Menopause 2018;25:21–8
   PubMed Web of Science ®Google Scholar
• Athanasiou S, Pitsouni E, Grigoriadis T, et al. Microablative fractional CO2 laser for the genitourinary syndrome of menopause: up to 12-month results. Menopause 2018;26:248–55.
   Web of Science ®Google Scholar
• González Isaza P, Jaguszewska K, Cardona JL, Lukaszuk M. Long-term effect of thermoablative fractional CO2 laser treatment as a novel approach to urinary incontinence management in women with genitourinary syndrome of menopause. Int Urogynecol J 2018;29:211–15
   PubMed Web of Science ®Google Scholar
• Pitsouni E, Grigoriadis T, Falagas ME, Salvatore S, Athanasiou S. Laser therapy for the genitourinary syndrome of menopause. A systematic review and meta-analysis. Maturitas 2017;103:78
   PubMed Web of Science ®Google Scholar
• Behnia-Willison F, Sarraf S, Miller J, et al. Safety and long-term efficacy of fractional CO2 laser treatment in women suffering from genitourinary syndrome of menopause. Eur J Obstet Gynecol Reprod Biol 2017;213:39–44
   PubMed Web of Science ®Google Scholar
• Athanasiou S, Pitsouni E, Falagas ME, Salvatore S, Grigoriadis T. CO2-laser for the genitourinary syndrome of menopause. How many laser sessions? Maturitas 2017;104:24–8
   PubMed Web of Science ®Google Scholar
• Pitsouni E, Grigoriadis T, Falagas M, Tsiveleka A, Salvatore S, Athanasiou S. Microablative fractional CO2 laser for the genitourinary syndrome of menopause: power of 30 or 40 W? Lasers Med Sci 2017;32:1865–72
   PubMed Web of Science ®Google Scholar
• Salvatore S, Pitsouni E, Del Deo F, Parma M, Athanasiou S, Candiani M. Sexual function in women suffering from genitourinary syndrome of menopause treated with fractionated CO2 laser. Sex Med Rev 2017;5:486–94
   PubMed Web of Science ®Google Scholar
• Sokol ER, Karram MM. Use of a novel fractional CO2 laser for the treatment of genitourinary syndrome of menopause: 1-year outcomes. Menopause 2017;24:810–14
   PubMed Web of Science ®Google Scholar
• Pitsouni E, Grigoriadis T, Tsiveleka A, Zacharakis D, Salvatore S, Athanasiou S. Microablative Fractional CO2-Laser therapy and the genitourinary syndrome of menopause: an observational study. Maturitas 2016;94:131–6
   PubMed Web of Science ®Google Scholar
• Athanasiou S, Pitsouni E, Antonopoulou A, et al. The effect of Microablative Fractional CO2 laser on vaginal flora of postmenopausal women. Climacteric 2016;19:512–18
   PubMed Web of Science ®Google Scholar
• Sokol E, Karram M. An assessment of the safety and efficacy of a fractional CO2 laser system for the treatment of vulvovaginal atrophy. Menopause 2016;23:1102–7
   PubMed Web of Science ®Google Scholar
• Perino A, Cucinella G, Gugliotta G, et al. Is vaginal fractional CO2 laser treatment effective in improving overactive bladder symptoms in post-menopausal patients? Preliminary results. Eur Rev Med Pharmacol 2016;20:2491–7
   PubMed Web of Science ®Google Scholar
• Perino A, Calligaro A, Forlani F, et al. Vulvo-vaginal atrophy: a new treatment modality using thermo-ablative fractional CO2 laser. Maturitas 2015;80:296–301
   PubMed Web of Science ®Google Scholar
• Salvatore S, Nappi RE, Parma M, et al. Sexual function after fractional microablative CO2 laser in women with vulvovaginal atrophy. Climacteric 2015;18:219–25
   PubMed Web of Science ®Google Scholar
• Salvatore S, Nappi RE, Zerbinati N, et al. A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study. Climacteric 2014;17:363–9
   PubMed Web of Science ®Google Scholar
• Zerbinati N, Serati M, Origoni M, et al. Microscopic and ultrastructural modifications of postmenopausal atrophic dioxide treatment. Lasers Med Sci 2015;30:429–36
   PubMed Web of Science ®Google Scholar
• Sturdee DW, Panay N, on behalf of the International Menopause Society Writing Group. Recommendations for the management of postmenopausal vaginal atrophy. Climacteric 2010;13:509–22
   PubMed Web of Science ®Google Scholar
• Gerlinger C, Schumacher U, Faustmann T, Colligs A, Schmitz H, Seitz C. Defining a minimal clinically important difference for endometriosis-associated pelvic pain measured on a visual analog scale: analyses of two placebo-controlled, randomized trials. Health Qual Life Outcomes 2010;8:138
   PubMed Web of Science ®Google Scholar
• Muin DA, Sheikh Rezaei S, Tremmel-Scheinost M, et al. Men's sexual response to female partner's intranasal oxytocin administration for hypoactive sexual desire disorder: an open prospective cohort study. Fertil Steril 2017;107:781–7
   PubMed Web of Science ®Google Scholar
• Gaetano J. (2018) Holm-Bonferroni sequential correction: An Excel calculator (1.3) [Microsoft Excel workbook]. Retrieved from:https://www.researchgate.net/publication/322568540_Holm-Bonferroni_sequential_correction_An_Excel_calculator_13 (last acessed 13.08.2019)
   Google Scholar
• Kim MK, Sim JA, Yun YH, et al. Health-Related Quality of Life and Sociodemographic Characteristics as Prognostic Indicators of Long-term Survival in Disease-Free Cervical Cancer Survivors. Int J Gynecol Cancer 2016;26:743–9
   PubMed Web of Science ®Google Scholar